Achieve recently announced that the FDA accepted its cytisinicline New Drug Application for treatment of nicotine dependence for smoking cessation, with a PDUFA target action date of June 20, 2026.
Mr. Donnelly has been with Achieve since 2022, serving as Executive Vice President, Chemistry, Manufacturing, and Controls (CMC) and Regulatory CMC. In his expanded role as Chief Operations Officer, ...
The Cool Down on MSN
Alarming new study reveals overlooked side effect of vaping on young people: 'The evidence supports policy measures'
Some reviews in the analysis also noted a higher chance of young people who vape turning to marijuana, alcohol, and stimulant ...
The Cool Down on MSN
Officials spark controversy with new rules meant to protect kids from harmful products: 'This is a bigger problem'
In an effort to combat this, an ordinance has been passed in Hanover County, Virginia, with more stringent regulations on new ...
With nicotine use among young adults rising, local public health advocates are still working to encourage similar bans at ...
Effective public health, financial aid, and regulatory interventions have proven benefits against disease and death. But many countries, not just the US, seem to be reversing their course—deliberately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback